Reg A+ IPO: The Only Cannabis Company with Federally Legal Product in US and Canada | Webinar On-Demand


Webinar Overview

Join True Leaf CEO and Board Director Darcy Bomford as he discusses an alternative investment in the only cannabis company with federally legal product in US and Canada.

True Leaf, the quality of life company for people and their pets, is seeking to raise up to $10 million CAD during its Reg A+ IPO and invites fans, customers, and supporters to invest at a discounted price per share than the current market price. During this webinar, Darcy will cover topics ranging from True Leaf’s innovative and safe hemp-based product line to the company’s plans to build out its cannabis production facilities.


Darcy Bomford
CEO, Board Director
True Leaf

Three decades of executive management experience and a 30-year history of manufacturing pet products in three federally inspected plants throughout the USA and Canada. Highly adept at building brands through corporate vision, strategy and the successful development of relationships with team members and strategic partners.





Legal Disclaimer:

This Presentation (the “Presentation”) has been prepared solely for informational purposes by True Leaf Medicine International Ltd. (“True Leaf”) and is being furnished through Boustead Securities, LLC (“Boustead Securities”) solely for use by prospective investors and other third parties in connection with their consideration of an investment in True Leaf. This presentation is not, and should not be assumed to be, complete. This presentation has been prepared to assist interested parties in making their own evaluation of True Leaf and does not purport to contain all of the information that may be relevant. In all cases, interested parties should conduct their own investigation and analysis of True Leaf and the data set forth in this presentation and other information provided by or on behalf of True Leaf. Any views and opinions expressed in this presentation are those of True Leaf and do not necessarily represent facts. In addition, certain of the information contained herein may be derived from information provided by industry sources. True Leaf believes that such information is accurate and that the sources from which it has been obtained are reliable. True Leaf cannot guarantee the accuracy of such information, however, and has not independently verified such information. The information presented herein remains subject to change. Statements in this presentation are made as of the date of this presentation unless stated otherwise.

SEC Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that True Leaf Medicine Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.

Forward-Looking Statements: This presentation also contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements.” Forward-looking statements are typically identified by the use of terms such as “may,” “should,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “potential” or the negative of such terms and other comparable terminology. The forward-looking statements included herein are based upon True Leaf’s current expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond True Leaf’ control. Although True Leaf believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, True Leaf’ actual results and performance and the value of its securities could differ materially from those set forth in the forward-looking statements due to the impact of many factors including, but not limited to, risks and uncertainties detailed in the “Risk Factors” in the Risk Factors section of True Leaf’ Offering Circular on Form 1-A, filed with the U.S. Securities and Exchange Commission and other discussions of risk factors contained in True Leaf’s periodic filings or supplements to the offering circular. True Leaf Offering Circular on Form 1-A can be found at True Leaf claims the safe harbor protection for forward looking statements contained in the Private Securities Litigation Reform Act of 1995. True Leaf undertakes no obligation to update or revise any such information for any reason after the date of this presentation, unless required by law.

Investment in True Leaf’s securities involves significant risks. You should purchase these securities only if you can afford a complete loss of your investment.

Leave a Comment